Sai Ramana Ponugoti appointed as CEO, ICH of Piramal Pharma
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
The order, part of an international framework agreement is to be executed between February to April, 2025
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Fiscal 2024 total sales for the joint venture were approximately $190 million
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
Subscribe To Our Newsletter & Stay Updated